Speaker Profile
M.D., Ph.D., Chief Medical and Scientific Officer, Verily
Biography
At Verily Dr. Trister leads the companys research, science and population health initiatives, providing expertise across Verilys portfolio as the company furthers its precision health strategy. Previously, Andrew served as the Deputy Director of Digital Health and Artificial Intelligence at The Bill Melinda Gates Foundation where he led the Foundations development and investment in digital health and artificial intelligence to address global health inequities. Prior to that, Andrew was a founding member of Apples Health team, where he led clinical research and machine learning with Apple partners. Andrew holds an MD, a PhD in bioengineering, an MSE and BSE in computer science, and a BA in biological basis of behavior from the University of Pennsylvania. He completed his clinical residency in radiation oncology at the University of Washington, with additional focus areas in medical and bioinformatics.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair:
Gad Getz, Broad Institute
- PMWC 2025 Luminary Award
Luminary Honoree: Jensen Huang, Nvidia
- Continued Jensen Huang, Nvidia
- Predictive Modeling for Drug Development
- Luca Emili, InSilicoTrials
- Knowledge Graphs, LLMs & Foundation Models for Enhanced Drug Development
- Janusz Dutkowski, Data4Cure
- Paul Rejto, Pfizer
- PMWC Showcase
- Peter Ellman, Certis Oncology
- Beyond LLMs: Harnessing Advanced AI Models for Genomics and Transcriptomics (PANEL)
Chair: Gad Getz, Broad Institute
- Yasin Şenbabaoğlu, CZ Biohub San Francisco
- Orly Alter, PrismAI
- Nicolo Fusi, Microsoft - Empowering AI in Precision Medicine with Federated Data Platforms
- Noah Nasser, Datma
- Advancing Global Health through Data Sharing: Practical Strategies and Success Stories (PANEL)
Chair: Luca Foschinii, Sage Bionetworks
- Peter Goodhand, GA4GH
- Karen Miga, UCSC
- Philip Awadalla, Ontario Institute for Cancer Research
- Driving Drug Discovery With Low-cost Foundational Omics Datasets
- Gilad Almogy, Ultima Genomics
- Johnny Yu, Vevo Therapeutics
- Stacie Calad-Thomson, NVDIA - Enabling Targeted Precision Drug & Gene Delivery with Predictive AI
- Andre Watson, Ligandal Inc.
- Quantum Leap: The Future of AI and Machine Learning with Quantum Computing
- Matthias Troyer, Microsoft
